MTOR and nonpapillary renal cell carcinoma: The results of this study demonstrated the increased expression of activated downstream effectors of PI3K/Akt/mTOR and Raf/MEK/ERK pathway in ccRCC tumor tissue compared to adjacent non-tumor tissue.